Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Aminocaproates MeSH
- Administration, Cutaneous MeSH
- Butyrates administration & dosage metabolism MeSH
- Diffusion Chambers, Culture MeSH
- Esterases analysis MeSH
- Griseofulvin administration & dosage metabolism MeSH
- Carbamates chemical synthesis pharmacology MeSH
- Clotrimazole administration & dosage metabolism MeSH
- Skin Absorption MeSH
- Skin drug effects metabolism MeSH
- Aminocaproic Acid chemical synthesis pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- Permeability MeSH
- Aged MeSH
- Theophylline administration & dosage metabolism MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Aminocaproates MeSH
- Butyrates MeSH
- dodecyl 6-aminocaproate MeSH Browser
- Esterases MeSH
- flobufen MeSH Browser
- Griseofulvin MeSH
- Carbamates MeSH
- Clotrimazole MeSH
- Aminocaproic Acid MeSH
- Theophylline MeSH
- transkarbam 12 MeSH Browser
PURPOSE: Dodecyl-6-aminohexanoate (DDEAC) is a transdermal permeation enhancer with excellent activity, low toxicity, and no dermal irritation. We hypothesized that DDEAC reacts with air CO2 to form a two-chain ammonium carbamate--Transkarbam 12 (T12)--which is responsible for the enhancing effect. METHODS: DDEAC and T12 were synthesized, their structures were confirmed by spectral methods, and their enhancing activity was studied using the Franz diffusion cell and human skin. A high-performance liquid chromatography method was developed for determination of T12, and its biodegradability was evaluated using porcine esterase. RESULTS: Only the carbamate salt T12 was responsible for the high enhancing activity; DDEAC tested under argon to avoid reaction with CO2 was inactive. T12 enhanced transdermal permeation of drugs covering a wide range of physicochemical properties, including theophylline (enhancement ratio up to 55.6), clotrimazole (7.7), flobufen (5.0), and griseofulvin (24). The activity was pH-dependent, further confirming the importance of the carbamate structure. The metabolization of T12 followed a second-order kinetics with t(1/2) = 31 min. CONCLUSION: Our results indicate that T12 is a promising biodegradable permeation enhancer for a wide range of drugs, and the structurally novel group of carbamate enhancers warrants further investigation.
See more in PubMed
Curr Med Chem. 2005;12(19):2273-91 PubMed
J Pharm Sci. 1996 Feb;85(2):150-4 PubMed
Arzneimittelforschung. 1997 May;47(5):648-52 PubMed
J Invest Dermatol. 1975 Mar;64(3):190-5 PubMed
Chem Phys Lipids. 2004 Apr;129(1):97-109 PubMed
Arch Dermatol. 1982 Jul;118(7):474-7 PubMed
Chem Rev. 2003 Oct;103(10):3857-98 PubMed
J Biophys Biochem Cytol. 1955 Jan;1(1):13-6 PubMed
J Control Release. 2005 May 5;104(1):41-9 PubMed
Drug Des Deliv. 1990 Jun;6(2):87-100 PubMed
Pharm Res. 1993 Jul;10(7):1015-9 PubMed
Nat Rev Drug Discov. 2004 Feb;3(2):115-24 PubMed
Adv Drug Deliv Rev. 2004 Mar 27;56(5):603-18 PubMed
Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery